Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael H Alderman

JAMA

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
JAMA|December 6, 2003
The return on INVESTMichael H Alderman
JAMA|November 19, 2002
Hypertension control and kidney disease: some questions answered, many remainMichael H Alderman
JAMA|February 4, 2010
Reducing dietary sodium: the case for cautionMichael H Alderman
JAMA|December 21, 2016
Reducing Sodium Intake in the PopulationDavid A McCarron, Michael H Alderman
JAMA|May 22, 2003
Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysisBruce M Psaty, Thomas Lumley, Curt D Furberg, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
JAMA|December 6, 2003
The return on INVESTMichael H Alderman
JAMA|November 19, 2002
Hypertension control and kidney disease: some questions answered, many remainMichael H Alderman
JAMA|February 4, 2010
Reducing dietary sodium: the case for cautionMichael H Alderman
JAMA|December 21, 2016
Reducing Sodium Intake in the PopulationDavid A McCarron, Michael H Alderman
JAMA|May 22, 2003
Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysisBruce M Psaty, Thomas Lumley, Curt D Furberg, et al.
Pageof 1